1. Preoperative Circulating Tumor DNA as a Guide to Evolve `Precision Onco-surgery´ in Resectable Colorectal Liver Metastases, 小林 信,髙橋進一郎,工藤雅史,杉本元一,小西 大,後藤田直人,第34回日本肝胆膵外科学会・学術集会,2022/6/11,国内,口頭.
国内 / 口頭
2. Yoshiaki Nakamura, Eric Van Cutsem, Tanios Bekaii-Saab, Josep Tabernero, Salvatore Siena, Kanwal Raghav, Andrea Cercek, Volker Heinemann, David Adelberg, James Ward, Shan Yang, John Strickler, Thierry Andre, Takayuki Yoshino. MOUNTAINEER-03: Ph 3 study of tucatinib, trastuzumab, and mFOLFOX6 as 1L treatment in HER2+ mCRC (TiP). 2023 the Japanese Society of Medical Oncology Annual Meeting. 2023/3/18, 国内, 口頭.
国内 / 口頭
3. Yoshiaki Nakamura, Multi-omics-based Precision Oncology for Patients with Advanced Solid Tumors. 2023 the Japanese Society of Medical Oncology Annual Meeting. 2023/3/17, 国内, 口頭.
国内 / 口頭
4. Yoshiaki Nakamura, Liquid Biopsy-guided Precision Oncology in Advanced Solid Tumors. 2023 the Japanese Society of Medical Oncology Annual Meeting. 2023/3/16, 国内, 口頭.
国内 / 口頭
5. Yoshiaki Nakamura. Biomarker-targeted therapies for gastric cancers: an emerging paradigm. The 95th Annual Meeting of the Japanese Gastric Cancer Association. 2023/2/24, 国内, 口頭.
国内 / 口頭
6. Yoshiaki Nakamura. Future Horizons of Precision Oncology. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022/10/22, 国内, 口頭.
国内 / 口頭
7. Yoshiaki Nakamura. Multi-omics-based Precision Oncology for Patients with Advanced Solid Tumors. The 81st Annual Meeting of the Japanese Cancer Association. 2022/10/1, 国内, 口頭.
国内 / 口頭
8. Yoshiaki Nakamura. Liquid biopsy-guided cancer precision medicine. The 42th Japan Society for Molecular Tumor Marker Research. 2022/9/28, 国内, 口頭.
国内 / 口頭
9. Yoshiaki Nakamura. Liquid biopsy-guided cancer precision medicine. The 63th Annual Spring Meeting of the Japanese Society of Clinical Oncology. 2022/6/11, 国内, 口頭.
国内 / 口頭